Oncology
From the Journals
Quality of life benefit exaggerated in some cancer studies
Feature
When too much treatment creates more harm than good
Some aggressive end-of-life care is associated with lower quality of life for patients, poorer bereavement for families.
From the Journals
Head and neck tumor grade may predict response to immunotherapy
Small study shows that high-grade head and neck tumors, not low grade, may be better suited for immunotherapy.
Highlights
What is palliative care and what’s new in practicing this type of medicine?
The common misperception is that palliative care is only for those at end of life or only in the advanced stages of their illness.
From the Journals
CRC screening disparities greatest among those under 55
Despite improvements in the proportion of people screened since 2000, disparities remain particularly high for younger adults and those with fewer...
From the Journals
Impact of eliminating cost-sharing on follow-up colonoscopy mixed
Eliminating cost-sharing of follow up colonoscopy after a positive noninvasive test led to a boost in follow-up colonoscopies in one state, but...
From the Journals
ASCO outlines optimal treatments for patients with metastatic clear cell renal cell carcinoma
A dramatic increase in therapy options prompted the first guidance issued by ASCO earlier this year.
Conference Coverage
Fatty liver disease drives rise in liver cancer deaths
The steep increase in liver cancer deaths is due to the rising rate of NAFLD and mostly driven by the obesity and type 2 diabetes epidemics.
From the Journals
‘Unexpected’: Breast cancer spreads most during sleep
The findings carry potential implications for the timing of biopsy and treatment of metastasis-prone cancers, the authors say.
From the Journals
Good chemo vs. bad chemo: When too much is a bad thing
Study questions the use of inpatient chemotherapy pointing to negative outcomes and high mortality among some patients.
Conference Coverage
Melanoma incidence is up, but death rates are down
“This is very encouraging data and represents the real-world effectiveness of these therapies.”